  {
"id": "T1839",
"authors": [
{
"name": "Douglas Pasternak",
"email": "dpasternak@usnews.com",
"affiliation": "U.S. News & World Report"
}
],
"conference": "IRE",
"year": "2003",
"title": "Biosafety Labs: New Threats - Chemical, Biological & Nuclear",
"description": "The National Institute of Allergy and Infectious Diseases (NIAID) plans to establish a network of new biodefense labs to conduct research on vaccines, diagnostic tests, and therapeutic agents to mitigate the deadly consequences of a biological terrorist attack. The network will consist of two National Biocontainment (BSL-4) Laboratories and ten Regional Biocontainment (BSL-3) Laboratories",
"keywords": [
"Biosafety Labs",
"Biodefense",
"Vaccines",
"Diagnostic Tests",
"Therapeutic Agents"
]
}
